Hrt Financial LP Synthetic Biologics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.9 - $2.9 $193,959 - $296,043	-102,084 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.3 - $4.3 $234,793 - $438,961	102,084 New	102,084 $29,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.5 $37,408 - $62,347	-13,855 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.3 - $5.8 $59,576 - $80,359	13,855 New	13,855 $6,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.